SITC 2019 Supporters

SITC gratefully acknowledges the following supporters of the society's 34th Annual Meeting & Pre-Conference Programs.

34th Annual Meeting

Double Platinum

AstraZeneca Pharmaceuticals LP

Platinum  

Bristol-Myers Squibb
Incyte Corporation
Merck & Co., Inc.

Gold

AbbVie
Amgen
Genentech
TESARO, Inc.

Silver

Eli Lilly and Company
Gilead Sciences, Inc.
Janssen Research & Development, LLC
Novartis Pharmaceuticals

Bronze

Bayer
Celgene Corporation
NanoString Technologies (The CheckPoints Party)
Pfizer, Inc.
Seattle Genetics, Inc.

Copper

7 Hills Pharma, LLC (The CheckPoints Party)
Fluidigm Corporation (The CheckPoints Party)
HalioDx (The CheckPoints Party)


Primer on Tumor Immunology and Cancer Immunotherapy

Silver

Merck & Co., Inc.

Bronze

Bristol-Myers Squibb
Celgene Corporation
Genentech

Copper

Pfizer, Inc.


Workshop on Intratumoral Immunomodulation

Bronze

Amgen
Celgene Corporation
Idera Pharmaceuticals

Copper

Pfizer, Inc.


Industry Program: Novel Multi-Targeted Therapeutic Platforms

Gold

Bristol-Myers Squibb

Silver

AstraZeneca Pharmaceuticals LP
Gilead Sciences, Inc.
Merck & Co., Inc.

Copper

Celgene Corporation
Pfizer, Inc.

World Immunotherapy Council's 3rd Young Investigator Symposium on Cancer Immunotherapy

Silver

Bristol-Myers Squibb

Bronze

Merck & Co., Inc.

Copper

Celgene Corporation
Pfizer, Inc.

Grant Writing Workshop: The study section black box: A look inside the grant review process

Bronze

Merck & Co., Inc.